The role of butyrate, a histone deacetylase inhibitor in diabetes mellitus: experimental evidence for therapeutic intervention | Epigenomics
Gut microbial short-chain fatty acids and the risk of diabetes | Nature Reviews Nephrology
Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology | Nature Communications
MECHANISMS IN ENDOCRINOLOGY: Gut microbiota in patients with type 2 diabetes mellitus in: European Journal of Endocrinology Volume 172 Issue 4 (2015)
Frontiers | Short-Chain Fatty Acids: A Soldier Fighting Against Inflammation and Protecting From Tumorigenesis in People With Diabetes
The short-chain fatty acid propionate increases glucagon and FABP4 production, impairing insulin action in mice and humans | Science Translational Medicine
New potential drug for type 2 diabetes treatment explored at MAX IV – MAX IV
Propionate ameliorates diabetes-induced neurological dysfunction through regulating the PI3K/Akt/eNOS signaling pathway - ScienceDirect
Frontiers | Gut Microbiota: An Important Player in Type 2 Diabetes Mellitus
Microbially Produced Imidazole Propionate Impairs Insulin Signaling through mTORC1 - ScienceDirect
Deutsches Institut für Ernährungsforschung: Propionate als Diabetes- und Herz-Kreislauf-Prävention, NewsWork AG, Pressemitteilung - lifePR
Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology | Nature Communications
Microbial Imidazole Propionate Affects Responses to Metformin through p38γ-Dependent Inhibitory AMPK Phosphorylation - ScienceDirect
Modulation of Short-Chain Fatty Acids as Potential Therapy Method for Type 2 Diabetes Mellitus
NutriOmics: Karine Clément's Lab on Twitter: "6/9 We also observed that subjects belonging to Bacteroides 2 enterotype had significantly increased serum ImP levels compared with other enterotypes. https://t.co/f2Ru6II28k" / Twitter
Intestinal microbiota and their metabolic contribution to type 2 diabetes and obesity | SpringerLink
Microbiota and diabetes: an evolving relationship | Gut
Frontiers | Therapeutic Potential of Butyrate for Treatment of Type 2 Diabetes
Gut microbiota-derived metabolites as key actors in type 2 diabetes mellitus - ScienceDirect
Bäckhed Lab
Nutrients | Free Full-Text | Type 2 Diabetes Mellitus Associated with Obesity (Diabesity). The Central Role of Gut Microbiota and Its Translational Applications
Propionate Consumption Increases Levels of Obesity- and Diabetes-Associated Hormones | Sci.News
